Molecular Imaging Market : TOC


Back to Report

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. XMR Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Molecular Imaging Market View Point Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regional Pricing Analysis by Product Type

3.4. Installed Base Analysis

4. North America Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

4.5.1. Positron Emission Tomography (PET)

4.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

4.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

4.5.4. Single Photon Emission Computed Tomography (SPECT)

4.5.5. Magnetic Resonance Spectroscopy

4.5.6. Molecular Ultrasound Imaging

4.5.7. Software

4.5.7.1. On Premises Solutions

4.5.7.2. Cloud Based Solutions

4.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

4.6.1. Positron Emission Tomography (PET)

4.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

4.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

4.6.4. Single Photon Emission Computed Tomography (SPECT)

4.6.5. Magnetic Resonance Spectroscopy

4.6.6. Molecular Ultrasound Imaging

4.6.7. Software

4.6.7.1. On Premises Solutions

4.6.7.2. Cloud Based Solutions

4.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

4.7.1. Hospitals

4.7.1.1. 500+ Beds

4.7.1.2. 200-499 Beds

4.7.1.3. Less than 200 Beds

4.7.2. Ambulatory Surgical Centers

4.7.3. Diagnostic Imaging Centers

4.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

4.8.1. Cardiology

4.8.2. Oncology

4.8.3. Gastrointestinal Disorders

4.8.4. Neurology Disorders

4.8.5. Others

4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

4.9.1. Cardiology

4.9.2. Oncology

4.9.3. Gastrointestinal Disorders

4.9.4. Neurology Disorders

4.9.5. Others

4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

4.10.1. Hospitals

4.10.1.1. 500+ Beds

4.10.1.2. 200-499 Beds

4.10.1.3. Less than 200 Beds

4.10.2. Ambulatory Surgical Centers

4.10.3. Diagnostic Imaging Centers

4.11. Drivers and Restraints: Impact Analysis

4.12. Market Attractiveness Analysis

4.12.1. By Country

4.12.2. By Modality

4.12.3. By Application

4.12.4. By End User

4.13. Key Representative Market Participants

4.14. Market Presence (Intensity Map)

5. Latin America Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

5.5.1. Positron Emission Tomography (PET)

5.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

5.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

5.5.4. Single Photon Emission Computed Tomography (SPECT)

5.5.5. Magnetic Resonance Spectroscopy

5.5.6. Molecular Ultrasound Imaging

5.5.7. Software

5.5.7.1. On Premises Solutions

5.5.7.2. Cloud Based Solutions

5.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

5.6.1. Positron Emission Tomography (PET)

5.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

5.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

5.6.4. Single Photon Emission Computed Tomography (SPECT)

5.6.5. Magnetic Resonance Spectroscopy

5.6.6. Molecular Ultrasound Imaging

5.6.7. Software

5.6.7.1. On Premises Solutions

5.6.7.2. Cloud Based Solutions

5.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

5.7.1. Hospitals

5.7.1.1. 500+ Beds

5.7.1.2. 200-499 Beds

5.7.1.3. Less than 200 Beds

5.7.2. Ambulatory Surgical Centers

5.7.3. Diagnostic Imaging Centers

5.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

5.8.1. Cardiology

5.8.2. Oncology

5.8.3. Gastrointestinal Disorders

5.8.4. Neurology Disorders

5.8.5. Others

5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

5.9.1. Cardiology

5.9.2. Oncology

5.9.3. Gastrointestinal Disorders

5.9.4. Neurology Disorders

5.9.5. Others

5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

5.10.1. Hospitals

5.10.1.1. 500+ Beds

5.10.1.2. 200-499 Beds

5.10.1.3. Less than 200 Beds

5.10.2. Ambulatory Surgical Centers

5.10.3. Diagnostic Imaging Centers

5.11. Drivers and Restraints: Impact Analysis

5.12. Market Attractiveness Analysis

5.12.1. By Country

5.12.2. By Modality

5.12.3. By Application

5.12.4. By End User

5.13. Key Representative Market Participants

5.14. Market Presence (Intensity Map)

6. Western Europe Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. BENELUX

6.3.7. Nordic

6.3.8. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. Italy

6.4.3. France

6.4.4. Spain

6.4.5. U.K.

6.4.6. BENELUX

6.4.7. Nordic

6.4.8. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

6.5.1. Positron Emission Tomography (PET)

6.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

6.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

6.5.4. Single Photon Emission Computed Tomography (SPECT)

6.5.5. Magnetic Resonance Spectroscopy

6.5.6. Molecular Ultrasound Imaging

6.5.7. Software

6.5.7.1. On Premises Solutions

6.5.7.2. Cloud Based Solutions

6.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

6.6.1. Positron Emission Tomography (PET)

6.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

6.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

6.6.4. Single Photon Emission Computed Tomography (SPECT)

6.6.5. Magnetic Resonance Spectroscopy

6.6.6. Molecular Ultrasound Imaging

6.6.7. Software

6.6.7.1. On Premises Solutions

6.6.7.2. Cloud Based Solutions

6.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

6.7.1. Hospitals

6.7.1.1. 500+ Beds

6.7.1.2. 200-499 Beds

6.7.1.3. Less than 200 Beds

6.7.2. Ambulatory Surgical Centers

6.7.3. Diagnostic Imaging Centers

6.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

6.8.1. Cardiology

6.8.2. Oncology

6.8.3. Gastrointestinal Disorders

6.8.4. Neurology Disorders

6.8.5. Others

6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

6.9.1. Cardiology

6.9.2. Oncology

6.9.3. Gastrointestinal Disorders

6.9.4. Neurology Disorders

6.9.5. Others

6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

6.10.1. Hospitals

6.10.1.1. 500+ Beds

6.10.1.2. 200-499 Beds

6.10.1.3. Less than 200 Beds

6.10.2. Ambulatory Surgical Centers

6.10.3. Diagnostic Imaging Centers

6.11. Drivers and Restraints: Impact Analysis

6.12. Market Attractiveness Analysis

6.12.1. By Country

6.12.2. By Modality

6.12.3. By Application

6.12.4. By End User

6.13. Key Representative Market Participants

6.14. Market Presence (Intensity Map)

7. Eastern Europe Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

7.5.1. Positron Emission Tomography (PET)

7.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

7.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

7.5.4. Single Photon Emission Computed Tomography (SPECT)

7.5.5. Magnetic Resonance Spectroscopy

7.5.6. Molecular Ultrasound Imaging

7.5.7. Software

7.5.7.1. On Premises Solutions

7.5.7.2. Cloud Based Solutions

7.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

7.6.1. Positron Emission Tomography (PET)

7.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

7.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

7.6.4. Single Photon Emission Computed Tomography (SPECT)

7.6.5. Magnetic Resonance Spectroscopy

7.6.6. Molecular Ultrasound Imaging

7.6.7. Software

7.6.7.1. On Premises Solutions

7.6.7.2. Cloud Based Solutions

7.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

7.7.1. Hospitals

7.7.1.1. 500+ Beds

7.7.1.2. 200-499 Beds

7.7.1.3. Less than 200 Beds

7.7.2. Ambulatory Surgical Centers

7.7.3. Diagnostic Imaging Centers

7.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

7.8.1. Cardiology

7.8.2. Oncology

7.8.3. Gastrointestinal Disorders

7.8.4. Neurology Disorders

7.8.5. Others

7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

7.9.1. Cardiology

7.9.2. Oncology

7.9.3. Gastrointestinal Disorders

7.9.4. Neurology Disorders

7.9.5. Others

7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

7.10.1. Hospitals

7.10.1.1. 500+ Beds

7.10.1.2. 200-499 Beds

7.10.1.3. Less than 200 Beds

7.10.2. Ambulatory Surgical Centers

7.10.3. Diagnostic Imaging Centers

7.11. Drivers and Restraints: Impact Analysis

7.12. Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Modality

7.12.3. By Application

7.12.4. By End User

7.13. Drivers and Restraints: Impact Analysis

7.14. Market Attractiveness Analysis

7.14.1. By Country

7.14.2. By Modality

7.14.3. By End User

7.15. Key Representative Market Participants

7.16. Market Presence (Intensity Map)

8. Asia Pacific excluding Japan Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

8.5.1. Positron Emission Tomography (PET)

8.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

8.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

8.5.4. Single Photon Emission Computed Tomography (SPECT)

8.5.5. Magnetic Resonance Spectroscopy

8.5.6. Molecular Ultrasound Imaging

8.5.7. Software

8.5.7.1. On Premises Solutions

8.5.7.2. Cloud Based Solutions

8.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

8.6.1. Positron Emission Tomography (PET)

8.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

8.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

8.6.4. Single Photon Emission Computed Tomography (SPECT)

8.6.5. Magnetic Resonance Spectroscopy

8.6.6. Molecular Ultrasound Imaging

8.6.7. Software

8.6.7.1. On Premises Solutions

8.6.7.2. Cloud Based Solutions

8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

8.7.1. Hospitals

8.7.1.1. 500+ Beds

8.7.1.2. 200-499 Beds

8.7.1.3. Less than 200 Beds

8.7.2. Ambulatory Surgical Centers

8.7.3. Diagnostic Imaging Centers

8.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

8.8.1. Cardiology

8.8.2. Oncology

8.8.3. Gastrointestinal Disorders

8.8.4. Neurology Disorders

8.8.5. Others

8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

8.9.1. Cardiology

8.9.2. Oncology

8.9.3. Gastrointestinal Disorders

8.9.4. Neurology Disorders

8.9.5. Others

8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

8.10.1. Hospitals

8.10.1.1. 500+ Beds

8.10.1.2. 200-499 Beds

8.10.1.3. Less than 200 Beds

8.10.2. Ambulatory Surgical Centers

8.10.3. Diagnostic Imaging Centers

8.11. Drivers and Restraints: Impact Analysis

8.12. Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Modality

8.12.3. By Application

8.12.4. By End User

8.13. Key Representative Market Participants

8.14. Market Presence (Intensity Map)

9. Japan Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

9.3.1. Positron Emission Tomography (PET)

9.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)

9.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

9.3.4. Single Photon Emission Computed Tomography (SPECT)

9.3.5. Magnetic Resonance Spectroscopy

9.3.6. Molecular Ultrasound Imaging

9.3.7. Software

9.3.7.1. On Premises Solutions

9.3.7.2. Cloud Based Solutions

9.4. Market Size (US$ Mn) Forecast By Modality, 2017–2027

9.4.1. Positron Emission Tomography (PET)

9.4.2. Positron Emission Tomography- Computed Tomography (PET-CT)

9.4.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

9.4.4. Single Photon Emission Computed Tomography (SPECT)

9.4.5. Magnetic Resonance Spectroscopy

9.4.6. Molecular Ultrasound Imaging

9.4.7. Software

9.4.7.1. On Premises Solutions

9.4.7.2. Cloud Based Solutions

9.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

9.5.1. Hospitals

9.5.1.1. 500+ Beds

9.5.1.2. 200-499 Beds

9.5.1.3. Less than 200 Beds

9.5.2. Ambulatory Surgical Centers

9.5.3. Diagnostic Imaging Centers

9.6. Market Size (US$ Mn) Forecast By Application, 2017–2027

9.6.1. Cardiology

9.6.2. Oncology

9.6.3. Gastrointestinal Disorders

9.6.4. Neurology Disorders

9.6.5. Others

9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

9.7.1. Cardiology

9.7.2. Oncology

9.7.3. Gastrointestinal Disorders

9.7.4. Neurology Disorders

9.7.5. Others

9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027

9.8.1. Hospitals

9.8.1.1. 500+ Beds

9.8.1.2. 200-499 Beds

9.8.1.3. Less than 200 Beds

9.8.2. Ambulatory Surgical Centers

9.8.3. Diagnostic Imaging Centers

9.9. Drivers and Restraints: Impact Analysis

9.10. Market Attractiveness Analysis

9.10.1. By Modality

9.10.2. By Application

9.10.3. By End User

9.11. Key Representative Market Participants

9.12. Market Presence (Intensity Map)

10. Middle East & Africa Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

10.5.1. Positron Emission Tomography (PET)

10.5.2. Positron Emission Tomography- Computed Tomography (PET-CT)

10.5.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

10.5.4. Single Photon Emission Computed Tomography (SPECT)

10.5.5. Magnetic Resonance Spectroscopy

10.5.6. Molecular Ultrasound Imaging

10.5.7. Software

10.5.7.1. On Premises Solutions

10.5.7.2. Cloud Based Solutions

10.6. Market Size (US$ Mn) Forecast By Modality, 2017–2027

10.6.1. Positron Emission Tomography (PET)

10.6.2. Positron Emission Tomography- Computed Tomography (PET-CT)

10.6.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

10.6.4. Single Photon Emission Computed Tomography (SPECT)

10.6.5. Magnetic Resonance Spectroscopy

10.6.6. Molecular Ultrasound Imaging

10.6.7. Software

10.6.7.1. On Premises Solutions

10.6.7.2. Cloud Based Solutions

10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

10.7.1. Hospitals

10.7.1.1. 500+ Beds

10.7.1.2. 200-499 Beds

10.7.1.3. Less than 200 Beds

10.7.2. Ambulatory Surgical Centers

10.7.3. Diagnostic Imaging Centers

10.8. Market Size (US$ Mn) Forecast By Application, 2017–2027

10.8.1. Cardiology

10.8.2. Oncology

10.8.3. Gastrointestinal Disorders

10.8.4. Neurology Disorders

10.8.5. Others

10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

10.9.1. Cardiology

10.9.2. Oncology

10.9.3. Gastrointestinal Disorders

10.9.4. Neurology Disorders

10.9.5. Others

10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027

10.10.1. Hospitals

10.10.1.1. 500+ Beds

10.10.1.2. 200-499 Beds

10.10.1.3. Less than 200 Beds

10.10.2. Ambulatory Surgical Centers

10.10.3. Diagnostic Imaging Centers

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Modality

10.12.3. By Application

10.12.4. By End User

10.13. Key Representative Market Participants

10.14. Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Structure

13.2. Market Share Analysis

13.3. Competition Dashboard

13.4. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

13.4.1. Hermes Medical Solutions

13.4.2. MIM Corporation

13.4.3. Bruker Corporation

13.4.4. GE Healthcare

13.4.5. Fujifilm Holdings Corp.

13.4.6. Siemens Healthcare

13.4.7. Koninklijke Philips N.V.

13.4.8. Toshiba Medical Systems Corporation

13.4.9. Hitachi Medical Corporation

13.4.10. Mediso kft.

13.4.11. Positron Corporation

13.4.12. ESAOTE S.P.A.

13.4.13. Carestream Health

13.4.14. Mirada Medical Limited

14. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Region

14.1. Introduction/Key Findings

14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific excluding Japan

14.2.6. Japan 

14.2.7. Middle East & Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017–2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific excluding Japan

14.3.6. Japan 

14.3.7. Middle East & Africa

14.4. Market Attractiveness Analysis By Region

15. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Modality

15.1. Introduction/Key Findings

15.2. Historical Market Size (US$ Mn) Trend Analysis By Modality, 2012–2016

15.2.1. Positron Emission Tomography (PET)

15.2.2. Positron Emission Tomography- Computed Tomography (PET-CT)

15.2.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

15.2.4. Single Photon Emission Computed Tomography (SPECT)

15.2.5. Magnetic Resonance Spectroscopy

15.2.6. Molecular Ultrasound Imaging

15.2.7. Software

15.2.7.1. On Premises Solutions

15.2.7.2. Cloud Based Solutions

15.3. Market Size (US$ Mn) Forecast By Modality, 2017–2027

15.3.1. Positron Emission Tomography (PET)

15.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)

15.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

15.3.4. Single Photon Emission Computed Tomography (SPECT)

15.3.5. Magnetic Resonance Spectroscopy

15.3.6. Molecular Ultrasound Imaging

15.3.7. Software

15.3.7.1. On Premises Solutions

15.3.7.2. Cloud Based Solutions

15.4. Market Attractiveness Analysis By Modality

16. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Application

16.1. Introduction/Key Findings

16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016

16.2.1. Cardiology

16.2.2. Oncology

16.2.3. Gastrointestinal Disorders

16.2.4. Neurology Disorders

16.2.5. Others

16.3. Market Size (US$ Mn) Forecast By Application, 2017–2027

16.3.1. Cardiology

16.3.2. Oncology

16.3.3. Gastrointestinal Disorders

16.3.4. Neurology Disorders

16.3.5. Others

16.4. Market Attractiveness Analysis By Application

17. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By End User

17.1. Introduction/Key Findings

17.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016

17.2.1. Hospitals

17.2.1.1. 500+ Beds

17.2.1.2. 200-499 Beds

17.2.1.3. Less than 200 Beds

17.2.2. Ambulatory Surgical Centers

17.2.3. Diagnostic Imaging Centers

17.3. Market Size (US$ Mn) Forecast By End User, 2017–2027

17.3.1. Hospitals

17.3.1.1. 500+ Beds

17.3.1.2. 200-499 Beds

17.3.1.3. Less than 200 Beds

17.3.2. Ambulatory Surgical Centers

17.3.3. Diagnostic Imaging Centers

17.4. Market Attractiveness Analysis By End User

18. Global Molecular Imaging Market Analysis 2012–2016 and Forecast 2017–2027

18.1. Market Size and Y-o-Y Growth

18.2. Absolute $ Opportunity

19. Research Methodology

Request Methodology of This Report

Request Methodology

First Time Buyer ?

Check Discount

Request a Sample

Click button below to request a sample of this report

Request Sample

About This Report


  • Rep Id : XPLREP849
  • Publised On : September, 2017
  • No. of Pages : 400
  • Category : Medical Imaging
  • Publisher : Future Market Insights